FDA Warns Consumers About Adverse Events Associated with Limbrel, a Dietary Supplement
date:Dec 07, 2017
l because of the risk of drug-induced liver injury, and a lung condition called hypersensitivity pneumonitis. Consumers taking this product should stop immediately and contact their health care provider. Health care providers who are aware that their patients are taking Limbrel should advise them to stop using it. Limbrel is available in capsule form in two dosages: Limbrel250 and Limbrel500.

Public health officials are investigating a rise in reports of serious adverse events involving the pro
2/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/06 03:05